Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase 2 9Phase 3 6Phase 1/2 2Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Glioblastoma 8Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 5Gliosarcoma 5Hodgkin Disease 4Central Nervous System Neoplasms 4Lymphoma, Follicular 3Oligodendroglioma 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Lymphoma 2Brain Neoplasms 2Astrocytoma 2Uveal Melanoma 1Sezary Syndrome 1Plasmablastic Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Infections 1

Interventions

Temozolomide 12Bevacizumab 8Carboplatin 6Radiotherapy 5Erlotinib Hydrochloride 5temsirolimus 3Surgical Procedures, Operative 3Irinotecan 3IL13-PE38 3veliparib 2pembrolizumab 2etoposide phosphate 2Vorinostat 2Specimen Handling 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Genetic Therapy 2Everolimus 2Cetuximab 2Carmustine 2Cancer Vaccines 2trastuzumab deruxtecan 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1terameprocol 1sonidegib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Astrocytoma × Carmustine × Clear all
NCT00009854 2013-11-06

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

National Cancer Institute (NCI)

Phase 1/2 Unknown
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00005855 2013-06-21

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

National Cancer Institute (NCI)

Phase 1/2 Completed
48 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡